They met, fell in love, started a gene therapy company. Now they've raised $104 million to target diseases that were unreachable.
The company's first target is Dravet syndrome, a rare genetic disorder marked by dozens of seizures a day. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 26, 2019 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Cellecta, Inc. Launches the First Commercially Available Dual-sgRNA Libraries for CRISPRa and CRISPRi Genetic Screens
Libraries of pooled lentiviral constructs that express two different sgRNA to all 19,000 human protein-coding genes improve overall gene activation or repression and generate more robust screening... (Source: The Scientist)
Source: The Scientist - June 26, 2019 Category: Science Tags: The Scientist The Marketplace Source Type: news

FDA Declines to Approve Acer Therapeutics' Treatment for Rare Genetic Disorder FDA Declines to Approve Acer Therapeutics' Treatment for Rare Genetic Disorder
Acer Therapeutics Inc said on Tuesday its treatment for a severe, rare genetic disorder that can cause blood vessels to fatally rupture was declined approval from the U.S. Food and Drug Administration.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 26, 2019 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

Despite the Headlines, We Don ’t Yet Know If Anticholinergic Drugs Contribute to Dementia Risk
There are a number of things that can increase the risk of dementia: age, of course, as well as certain genetic profiles and behaviors such as smoking and drinking. Some of the same things that contribute to heart disease, such as high cholesterol levels and the build up of plaques in the blood vessels, can also boost the chances of developing dementia. And in a large study published in JAMA Internal Medicine conducted in the UK, researchers report another possible factor: a group of drugs known as anticholinergics. These include prescription medications for treating depression, pulmonary disease, and Parkinson’s, as...
Source: TIME: Health - June 26, 2019 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Brain Dementia Drugs Source Type: news

With $10 million boost from Broad Foundation, UCSF aims to 'unravel' genetic diseases
A new $30 million stem cell research gift from the Eli and Edythe Broad Foundation will help UCSF find more promising early treatments, including those delivered to a fetus. The University of California, San Francisco, will receive one-third of the gift, part of $113 million given by the foundation of businessman Eli Broad and his wife toward stem cell research in California since 2005. Stem cell centers at UCLA and the University of Southern California will also get $10 million each. Disclosure… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 26, 2019 Category: American Health Authors: Ron Leuty Source Type: news

They met, fell in love, started a gene therapy company — now they've raised $104 million to target diseases that were unreachable
The company's first target is Dravet syndrome, a rare genetic disorder marked by dozens of seizures a day. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 26, 2019 Category: American Health Authors: Ron Leuty Source Type: news

What You Should Know About Insurance Before You Have Genetic Testing
Are you considering genetic testing? Consider your insurance options first. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 26, 2019 Category: Pharmaceuticals Authors: Ellen Matloff, Contributor Source Type: news

No interaction between childhood maltreatment and serotonin transporter gene in recurrent major depressive disorder: a clinical sample - Özçürümez G, Yurdakul HT, Terzi Y, Direk N, Eşsizoğlu A, Şahin F.
INTRODUCTION: There is inconsistent evidence of interaction between childhood adversities and a serotonin transporter promoter polymorphism (5-HTTLPR) in depression. It is hypothesized that genetic sensitivity to stress could be more specific to recurrent ... (Source: SafetyLit)
Source: SafetyLit - June 26, 2019 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Genetic and environmental predictors of adolescent PTSD symptom trajectories following a natural disaster - Sheerin CM, Kovalchick LV, Overstreet C, Rappaport LM, Williamson V, Vladimirov V, Ruggiero KJ, Amstadter AB.
: Genes, environmental factors, and their interplay affect posttrauma symptoms. Although environmental predictors of the longitudinal course of posttraumatic stress disorder (PTSD) symptoms are documented, there remains a need to incorporate genetic... (Source: SafetyLit)
Source: SafetyLit - June 26, 2019 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

UCLA receives $10 million from The Eli and Edythe Broad Foundation
UCLA has received a $10 million gift fromThe Eli and Edythe Broad Foundation to fund education, faculty recruitment and retention, and innovative research at the campus ’s stem cell research center. The foundation also announced $10 million gifts to the Broad family’s namesake stem cell research centers UC San Francisco and the University of Southern California, bringing its total support of stem cell research centers in California to $110 million since 2005.      “We are proud to support California’s growing stem cell research and treatment infrastructure led by the talented sci...
Source: UCLA Newsroom: Health Sciences - June 26, 2019 Category: Universities & Medical Training Source Type: news

AHA News: Genetics May Help Predict the Right Blood Pressure Drug for You
Title: AHA News: Genetics May Help Predict the Right Blood Pressure Drug for YouCategory: Health NewsCreated: 6/25/2019 12:00:00 AMLast Editorial Review: 6/26/2019 12:00:00 AM (Source: MedicineNet High Blood Pressure General)
Source: MedicineNet High Blood Pressure General - June 26, 2019 Category: Cardiology Source Type: news

Preimplantation Genetic Testing for Multiple Conditions Preimplantation Genetic Testing for Multiple Conditions
This paper explores the clinical and ethical issues surrounding preimplantation genetic testing when requested for more than one condition. Is cPGT-M/SR feasible for couples at high risk?Human Reproduction (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 26, 2019 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news

Scientists developing way to help premature babies breathe easier
(Cincinnati Children's Hospital Medical Center) Researchers suggest a possible cell-based therapy to stimulate lung development in fragile premature infants who suffer from a rare condition called Bronchopulmonary Dysplasia (BPD), which in the most severe cases can lead to lifelong breathing problems and even death. Scientists report in the American Journal of Respiratory and Critical Care Medicine they studied genetic signatures in donated human neonatal lungs by using single-cell RNA sequencing analysis and mouse models of BPD. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 26, 2019 Category: International Medicine & Public Health Source Type: news

New study on gene editing in wildlife finds people are wary
(University of Central Florida) The applications of CRISPR based genetic engineering tools range from changing colors in butterfly wings to developing gene therapies that might one day cure or prevent human diseases. Some scientists are also setting their sights on new uses -- saving endangered species and possibly eliminating invasive ones to manage wildlife populations for conservation. However, a University of Central Florida researcher and her colleagues have found that people living in the US are wary of using this technology to achieve wildlife conservation goals. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 26, 2019 Category: International Medicine & Public Health Source Type: news

Genetically modified virus combats prostate cancer
(Funda ç ã o de Amparo à Pesquisa do Estado de S ã o Paulo) In a study with mice, a gene therapy developed in Brazil kills cancer cells and avoids adverse side effects when combined with chemotherapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 26, 2019 Category: International Medicine & Public Health Source Type: news

U.S. pork lobby says regulatory changes needed after Trump biotech order
The U.S. pork lobby said on Tuesday that more must be done to simplify regulations for genetically altered livestock, weeks after President Donald Trump signed an executive order to streamline the review process for agricultural technology. (Source: Reuters: Health)
Source: Reuters: Health - June 26, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

FDA declines to approve Acer Therapeutics' rare genetic disorder treatment
Acer Therapeutics Inc said on Tuesday the U.S. Food and Drug Administration declined to approve its treatment for a severe, rare genetic disorder that can cause blood vessels to fatally rupture, sending its shares plunging as much as 78%. (Source: Reuters: Health)
Source: Reuters: Health - June 25, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Should we resurrect the American chestnut tree with genetic engineering?
Genetic engineering could help save chestnuts and other trees threatened by pests, disease and climate change. But how much we should intervene in nature? (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - June 25, 2019 Category: Science Authors: Julia Rosen Source Type: news

FDA declines to approve Acer Therapeutics' treatment for rare genetic disorder
Acer Therapeutics Inc said on Tuesday its treatment for a severe, rare genetic disorder that can cause blood vessels to fatally rupture was declined approval from the U.S. Food and Drug Administration. (Source: Reuters: Health)
Source: Reuters: Health - June 25, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

AHA News: Genetics May Help Predict the Right Blood Pressure Drug for You
TUESDAY, June 25, 2019 (American Heart Association News) -- Medication can play a huge role in reducing high blood pressure, a leading cause of stroke, heart attack and other serious health problems. Yet given the wide selection of drugs for doctors... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 25, 2019 Category: General Medicine Source Type: news

What the Science Really Says About Grilled Meat and Cancer Risk
As backyard cookout season kicks into high gear, many people may be eyeing their sizzling burgers and dogs with suspicion. And for good reason: a number of studies published in the past two decades have turned up evidence that eating charred, smoked, and well-done meat could raise cancer risk—pancreatic, colorectal, and prostate cancers, in particular. A 2010 review of the evidence on cancer and “well-done” meat, conducted by researchers at Vanderbilt University, concluded that “the majority of these studies have shown that high intake of well-done meat and high exposure to meat carcinogens, particu...
Source: TIME: Health - June 25, 2019 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Cancer Diet & Fitness Nutrition Source Type: news

How human genetic data is helping dogs fight cancer
(University of Colorado Anschutz Medical Campus) Colorado study sequences 33 canine cancer cell lines to identify 'human' genetic changes could be driving these canine cancers, possibly helping veterinary oncologists use more human medicines to cure cancer in dogs. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 25, 2019 Category: International Medicine & Public Health Source Type: news

Predictors of cognitive recovery following mild to severe traumatic brain injury
(Mary Ann Liebert, Inc./Genetic Engineering News) Researchers have shown that higher intelligence and younger age are predictors of greater cognitive recovery 2-5 years post-mild to severe traumatic brain injury (TBI). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 25, 2019 Category: International Medicine & Public Health Source Type: news

LGBTI adolescents and young adults with cancer: Can we do better?
(Mary Ann Liebert, Inc./Genetic Engineering News) A new systemic review of the literature has shown a clear gap in the understanding of cancer in lesbian, gay, bisexual, transgender and/or intersex (LGBTI) adolescents and young adults (AYA). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 25, 2019 Category: International Medicine & Public Health Source Type: news

ActX Launches a Genetic Medical Interpretation Service for 23andMe...
ActX has launched a medical genetic interpretation service for 23andMe customers.(PRWeb June 25, 2019)Read the full story at https://www.prweb.com/releases/actx_launches_a_genetic_medical_interpretation_service_for_23andme_customers/prweb16392798.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 25, 2019 Category: Pharmaceuticals Source Type: news

Researcher looks for ways to detect deadly cancer before it develops
Out of the 22,240 women in the United States who are diagnosed with ovarian cancer every year, only about 47 percent survive longer than five years.But Dr. Beth Karlan, the newly appointed director of cancer population genetics atUCLA ’s Jonsson Comprehensive Cancer Center, is hopeful that her research will not only help women get diagnosed with ovarian cancer at an earlier stage, but also identify the women who are most at-risk so they can intervene before the cancer even develops.In this interview, Karlan, who is also the vice chair of women ’s health research in the obstetrics and gynecology department in th...
Source: UCLA Newsroom: Health Sciences - June 24, 2019 Category: Universities & Medical Training Source Type: news

Got man boobs? It's not the soy, it's the BEER
(Natural News) If you listen to your medical doctor, who knows very little about nutrition, you may think those man boobs are genetic, or caused by obesity, drugs (legal and illegal), or most likely soy, but you would be way off. What’s really affecting those hormones and influencing them so badly that thousands of men... (Source: NaturalNews.com)
Source: NaturalNews.com - June 24, 2019 Category: Consumer Health News Source Type: news

Evidence for interaction between genetic liability and childhood trauma in the development of psychotic symptoms - Pinckaers FME, Rotee ILM, Nwosu CV, Krolinski P, Smeets APW, G ülöksüz S, de Jong L, Vaessen TSJ, Damen T, Uittenboogaard A, Schäfer AT, Menne-Lothmann C, Decoster J, van Winkel R, Collip D, Delespaul P, De Hert M, Derom C, Thiery E, Jacobs N, Wichers M, Rutten BPF, van Os J, Drukker M.
PURPOSE: Whilst childhood trauma (CT) is a known risk factor across the spectrum of psychosis expression, little is known about possible interplay with genetic liability. METHODS: The TwinssCan Study collected data in general population twins, focu... (Source: SafetyLit)
Source: SafetyLit - June 24, 2019 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Amid donor screening concerns, sperm bank industry is "buyer beware"
A New York City sperm bank faces multiple lawsuits, claiming it did not properly screen its donors for genetic diseases. The sperm bank industry is expected to be worth more than $5 billion by 2025, but some families say they're learning troubling information after the fact. Anna Werner reports. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - June 24, 2019 Category: Consumer Health News Source Type: news

Why the sperm bank industry is "buyer beware"
A NYC sperm bank faces multiple lawsuits that claim it did not properly screen its donors for genetic diseases (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - June 24, 2019 Category: Consumer Health News Source Type: news

FDA Expands Cystic Fibrosis Treatment Approval for Symdeko (Tezacaftor/ivacaftor) to Children Ages 6 to 12
MONDAY, June 24, 2019 -- The indication for a cystic fibrosis treatment, Symdeko (tezacaftor/ivacaftor) tablets, has been expanded to treat children ages 6 years and older with cystic fibrosis and certain genetic mutations, the U.S. Food and Drug... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 24, 2019 Category: General Medicine Source Type: news

Medical cannabis group EMMAC forms research partnership with Hyris Ltd
European medical cannabis company EMMAC announced on Monday a research partnership with UK biotechnology company Hyris Limited to develop a library of genetic profiles of existing cannabis varieties. (Source: Reuters: Health)
Source: Reuters: Health - June 24, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Researchers identify genes linked to sex differentiation in giant Amazon fish
(Funda ç ã o de Amparo à Pesquisa do Estado de S ã o Paulo) Discoveries by Brazilian and German researchers may facilitate early sexing of pirarucu (arapaima) and its reproduction in captivity while also paving the way for genetic improvement. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 24, 2019 Category: International Medicine & Public Health Source Type: news

Alzheimer's disease: Sex affects tau accumulation in the brain
(Society of Nuclear Medicine and Molecular Imaging) The strongest genetic risk factor for Alzheimer's disease is the apolipoprotein E type 4 allele (ApoEε4). Research presented by Manish Paranjpe at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) used positron emission tomography (PET) to show that women who are ApoEε4 carriers and already experiencing mild cognitive impairment are more susceptible than men to tau accumulation in the brain. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 24, 2019 Category: International Medicine & Public Health Source Type: news

Close-range blast exposure & neurodegenerative processes among those with genetic risk for AD
(Boston University School of Medicine) A new study raises the possibility that close-range blast exposure among veterans with a genetically higher risk for Alzheimer's disease (AD), may make them more susceptible to degradation of their white matter, the part of the brain made of fiber connections called axons that connect nerve cells. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 24, 2019 Category: International Medicine & Public Health Source Type: news

Broad Institute researchers use novel field-ready CRISPR platform to detect plant genes
(Mary Ann Liebert, Inc./Genetic Engineering News) SHERLOCK technology is a new CRISPR-based platform that is rapid and portable and enables detection and quantitation of plant genes to support a variety of agricultural applications. Additional advantages, including the ability to process crude plant extracts with minimal nucleic acid sample preparation required are described in a research article published in The CRISPR Journal, a new peer-reviewed journal from Mary Ann Liebert, Inc., publishers. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 24, 2019 Category: Biology Source Type: news

FDA expands approval of treatment for cystic fibrosis to include patients ages 6 and older
FDA expanded the indication for Symdeko for treatment of pediatric patients ages 6 years and older with cystic fibrosis who have certain genetic mutations. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 22, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA Expands Use of Symdeko for Cystic Fibrosis to Younger Children FDA Expands Use of Symdeko for Cystic Fibrosis to Younger Children
The FDA has approved tezacaftor/ivacaftor tablets for use in children as young as 6 years with cystic fibrosis with certain genetic mutations in the CFTR gene.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 21, 2019 Category: Consumer Health News Tags: Pulmonary Medicine News Alert Source Type: news

Scientists Have Recorded A Rare Right Whale Singing For the First Time. It Does Have the Range
(ANCHORAGE, Alaska) — It’s not America’s Top 40, but it’s a cutting edge song. Federal marine biologists for the first time have recorded singing by one of the rarest whales on the planet, the North Pacific right whale. National Oceanic and Atmospheric Administration researchers used moored acoustic recorders to capture repeated patterns of calls made by male North Pacific right whales. Only about 30 of the animals remain. Whalers nearly wiped out the slow-moving whales, which remain buoyant after they are killed. It’s the first time right whale songs in any population have been documented, sa...
Source: TIME: Science - June 21, 2019 Category: Science Authors: DAN JOLING / AP Tags: Uncategorized Alaska onetime Science Whales Source Type: news

FDA Expands Cystic Fibrosis Treatment Approval to Children Ages 6 to 12
FRIDAY, June 21, 2019 -- The indication for a cystic fibrosis treatment, Symdeko (tezacaftor/ivacaftor) tablets, has been expanded to treat children ages 6 years and older with cystic fibrosis and certain genetic mutations, the U.S. Food and Drug... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 21, 2019 Category: Pharmaceuticals Source Type: news

Prominent Mouse Genetics Center Could be Shuttered
Staff at the UK’s Harwell Institute were notified that a strategy board recommended halting its academic work, but a final decision is months away. (Source: The Scientist)
Source: The Scientist - June 21, 2019 Category: Science Tags: News & Opinion Source Type: news

How to improve adoption of genetic testing into provider workflow?
Flare Capital Partners offers an overview of sequencing options, opportunities for integration into clinical workflow and the companies making that happen. (Source: mobihealthnews)
Source: mobihealthnews - June 21, 2019 Category: Information Technology Source Type: news

Restaurants could be first to get genetically modified salmon
Companies like AquaBounty are ready to serve up genetically altered fish, though consumer groups urge caution (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - June 21, 2019 Category: Consumer Health News Source Type: news

Incysus Therapeutics receives US patent for its technology
Biopharma company Incysus Therapeutics has been issued a patent by the U.S. Patent and Trademark Office for “Drug Resistant Immunotherapy for treatment of a cancer.”  According to the company, the patent covers the treatment of brain cancer with the combination of certain chemotherapies and a T cell genetically modified to confer chemotherapy resistance.  According to the company, Incysus has two Investigational New Drug applications (INDs) approved by the U.S. Food and Drug Administration… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - June 21, 2019 Category: Health Management Authors: Tyler Patchen Source Type: news

Incysus Therapeutics receives US patent for its technology
Biopharma company Incysus Therapeutics has been issued a patent by the U.S. Patent and Trademark Office for “Drug Resistant Immunotherapy for treatment of a cancer.”  According to the company, the patent covers the treatment of brain cancer with the combination of certain chemotherapies and a T cell genetically modified to confer chemotherapy resistance.  According to the company, Incysus has two Investigational New Drug applications (INDs) approved by the U.S. Food and Drug Administration… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 21, 2019 Category: Biotechnology Authors: Tyler Patchen Source Type: news

Media alert: New articles in The CRISPR Journal from MIT, Harvard, Editas, and others
(Mary Ann Liebert, Inc./Genetic Engineering News) The CRISPR Journal announces the publication of its June 2019 issue with articles from MIT, Harvard, Editas, Inscripta, and others. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 21, 2019 Category: Biology Source Type: news

Virtual reality takes a leap into taste
(Champalimaud Centre for the Unknown) optoPAD is a newly developed system for creating virtual taste realities. It combines advanced optical and genetic techniques with touch-screen technology to monitor and control feeding behaviors and taste sensations in fruit flies. This new tool, which is now being freely shared with the scientific community, significantly extends the toolset available to study feeding behavior in this model organism, which in turn may provide important insight into the neural circuitry that underlies food choice. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 21, 2019 Category: International Medicine & Public Health Source Type: news

Children with birth defects have up to 12 times higher cancer risks
Children born with defects of known genetic origins are at a 12-fold higher risk of cancer, and those with defects of unknown origins are at a 2.5-fold increased risk of cancer, Baylor College research found. (Source: the Mail online | Health)
Source: the Mail online | Health - June 20, 2019 Category: Consumer Health News Source Type: news

UK's leading mouse genetics centre faces closure
Plan to halt academic work at Harwell Institute threatens research including on diabetesBritain ’s leading centre for mouse genetics is facing closure in a move that critics say will undermine crucial research on serious diseases and threaten the standing of UK science.The Medical Research Council has told staff at its Harwell Institute in Oxfordshire that an internal strategy board recommended the closure of all academic work at the site, threatening research on diabetes, neurodegenerative disease, child deafness and other conditions.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - June 20, 2019 Category: Science Authors: Ian Sample Science editor Tags: Genetics Science UK news Biology Source Type: news

Dr Henry Lynch obituary
Geneticist who unlocked the secrets of hereditary cancersIn 1962 a medical intern sat with a man recovering from alcohol poisoning in a veterans ’ hospital in the US state of Nebraska. Henry Lynch, who has died aged 91, listened as the young farm worker told him that he liked to drown his sorrows because, as with everyone else in his family, he was pretty much guaranteed to die young of cancer.Lynch, with a background in genetics and psychology, wanted to know more about this family and its high prevalence of cancer. His investigations intothis and other such families led to the discovery of hereditary non-polyposis ...
Source: Guardian Unlimited Science - June 20, 2019 Category: Science Authors: Penny Warren Tags: Genetics Biology People in science Cancer research Medical research Medicine Education Source Type: news